News

PEG-Liposome siRNA In Vivo Transfection Kit From Altogen

Altogen announced the release of its second generation of in vivo RNAi transfection reagent in the company’s popular in vivo delivery product line: PEG-Liposome siRNA In Vivo Transfection Kit. This reagent is compatible for in vivo transfection of other negatively charged molecules – RNA, DNA, and small proteins. The company also offers custom encapsulation of target molecules Read Continue Reading

Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products

Altogen Labs announced the filing of a patent for bioremediation microorganism isolation and selection methods (USPTO application 13/490,508). This environmental technology is based on isolation of naturally present microorganisms in heavily contaminated soil, which allows accelerating natural bioremediation processes. We don’t have to wait hundreds of years for nature to degrade an oil spill or… Continue Reading

Texas-Based Biotechnology Company Develops Oil-Degrading Bacteria

Altogen Labs announced that it has successfully isolated natural oil-eating bacteria from polluted soil near Galveston Bay, Texas that has been shown in laboratory tests to be effective for the bioremediation of crude oil and petroleum saturated earth. Bioremediation is a process involving microorganisms, fungi, green plants, or their enzymes to restore the natural environment to… Continue Reading

Altogen Labs Microorganism ID: Bacteria Identification Service

Altogen Labs, a preclinical contract research laboratory, announced its launch of microorganism ID bacteria identification service. Microorganism identification and bioinformatic sequence characterization services are available for all types of bacteria, fungi, yeast, algae, soil, animal, and microbial samples for both R&D research studies and clinical applications. Microorganism identification service is designed to support and accelerate… Continue Reading

Altogen Labs Company Profile

Altogen Labs, a GLP-compliant laboratory located in Austin, Texas (USA), provides pharmacology and biotechnology contract research services worldwide. Company offers innovative life science research services, including safety and efficacy pre-clinical studies, validated xenograft models, in vivo pharmacology services, development of stable cell lines, in vivo biodistribution, RNAi gene silencing services, ELISA assay development, gene targeting,… Continue Reading